Zhiding Medical Technology (Hangzhou)

Zhiding Medical Technology (Hangzhou) Co., Ltd. is a Chinese high-tech enterprise focused on the research, development, manufacturing, and sales of high-precision optical medical equipment, particularly in the field of ophthalmology. The company was initially established in Nanjing in 2012, specializing in vein visualization products. In 2015, the headquarters were relocated to Hangzhou, a move that marked a strategic pivot towards comprehensive ophthalmic solutions. Zhiding Medical was founded by a group of overseas professors and brings together experts in optics and precision machinery from both China and the United States. The founder, Dr. Tang Lei, has been actively involved in discussions on medical equipment innovation and cooperation.

The company's business model revolves around the direct sale of its proprietary medical devices to healthcare providers worldwide. Its client base includes hospitals and specialized eye clinics. Zhiding Medical operates in the high-tech medical device market, with a significant emphasis on ophthalmology. Key milestones for the company include developing China's first ophthalmic Optical Coherence Tomography Angiography (OCTA) in 2016, obtaining National Class II medical machinery production licenses in 2017, and launching its widely acclaimed OCTA/OCT products in 2018. Between 2019 and 2022, the firm established the Zhiding Cloud Film Reading Center for remote OCT assistance, secured multiple rounds of funding, and entered into strategic cooperations with Lumenis and the Suzhou Institute of Biomedical Engineering Technology. In the third quarter of 2022, the company successfully completed a 50 million RMB Series B financing round.

Zhiding Medical's product portfolio addresses critical needs in diagnostics and treatment. Its core offerings include Optical Coherence Tomography (OCT) and OCTA scanners, which provide non-invasive, high-resolution imaging of retinal structures to diagnose fundus diseases. Another major focus is on dry eye disease, for which the company manufactures a comprehensive suite of products including the D500 and D600 Dry Eye Analyzers/Detectors. These devices assist in diagnosing Meibomian Gland Dysfunction (MGD) by capturing clear images of the glands and tear film. For treatment, Zhiding offers an Intense Pulsed Light (IPL) therapy system and an Atomizing Fumigator, which uses a heated, atomized mist to moisturize the eyes. The company also continues to produce its original vein visualization systems, which use infrared light to help with venipuncture.

Keywords: ophthalmic devices, optical coherence tomography, OCTA, dry eye diagnosis, dry eye treatment, Meibomian Gland Dysfunction, vein finder, medical imaging technology, vein visualization, ophthalmic solutions, IPL therapy for dry eye, medical device manufacturer, Hangzhou medtech, optical medical equipment, retinal imaging, fundus disease diagnosis, Dr. Tang Lei, non-invasive diagnostics, atomizing fumigator, infrared light medical device